{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,8]],"date-time":"2026-06-08T15:30:04Z","timestamp":1780932604329,"version":"3.54.1"},"reference-count":44,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2023,11,1]],"date-time":"2023-11-01T00:00:00Z","timestamp":1698796800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2023,11,1]],"date-time":"2023-11-01T00:00:00Z","timestamp":1698796800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2023,11,1]],"date-time":"2023-11-01T00:00:00Z","timestamp":1698796800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2023,11,1]],"date-time":"2023-11-01T00:00:00Z","timestamp":1698796800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2023,11,1]],"date-time":"2023-11-01T00:00:00Z","timestamp":1698796800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2023,11,1]],"date-time":"2023-11-01T00:00:00Z","timestamp":1698796800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2023,11,1]],"date-time":"2023-11-01T00:00:00Z","timestamp":1698796800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["International Immunopharmacology"],"published-print":{"date-parts":[[2023,11]]},"DOI":"10.1016\/j.intimp.2023.110917","type":"journal-article","created":{"date-parts":[[2023,9,14]],"date-time":"2023-09-14T09:46:01Z","timestamp":1694684761000},"page":"110917","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":23,"special_numbering":"PA","title":["The effect of artesunate to reverse CLP-induced sepsis immunosuppression mice with secondary infection is tightly related to reducing the apoptosis of T cells via decreasing the inhibiting receptors and activating MAPK\/ERK pathway"],"prefix":"10.1016","volume":"124","author":[{"given":"Yue","family":"Yuan","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ling","family":"Hua","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jun","family":"Zhou","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dan","family":"Liu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Fumin","family":"Ouyang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xuemin","family":"Chen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shujuan","family":"Long","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yasi","family":"Huang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xin","family":"Liu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jiang","family":"Zheng","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-6336-5854","authenticated-orcid":false,"given":"Hong","family":"Zhou","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"8","key":"10.1016\/j.intimp.2023.110917_b0005","doi-asserted-by":"crossref","first-page":"801","DOI":"10.1001\/jama.2016.0287","article-title":"The Third International Consensus Definitions for Sepsis and Septic Shock (Sepsis-3)","volume":"315","author":"Singer","year":"2016","journal-title":"JAMA."},{"issue":"10219","key":"10.1016\/j.intimp.2023.110917_b0010","doi-asserted-by":"crossref","first-page":"200","DOI":"10.1016\/S0140-6736(19)32989-7","article-title":"Global, regional, and national sepsis incidence and mortality, 1990\u20132017: analysis for the Global Burden of Disease Study","volume":"395","author":"Rudd","year":"2020","journal-title":"Lancet"},{"issue":"1","key":"10.1016\/j.intimp.2023.110917_b0015","doi-asserted-by":"crossref","first-page":"4","DOI":"10.4161\/viru.27372","article-title":"Epidemiology of severe sepsis","volume":"5","author":"Mayr","year":"2014","journal-title":"Virulence"},{"issue":"1","key":"10.1016\/j.intimp.2023.110917_b0020","doi-asserted-by":"crossref","first-page":"23","DOI":"10.1172\/JCI82224","article-title":"Sepsis-induced immune dysfunction: can immune therapies reduce mortality","volume":"126","author":"Delano","year":"2016","journal-title":"J. Clin. Invest."},{"issue":"23","key":"10.1016\/j.intimp.2023.110917_b0025","doi-asserted-by":"crossref","first-page":"2594","DOI":"10.1001\/jama.2011.1829","article-title":"Immunosuppression in patients who die of sepsis and multiple organ failure","volume":"306","author":"Boomer","year":"2011","journal-title":"Jama"},{"issue":"5","key":"10.1016\/j.intimp.2023.110917_b0030","doi-asserted-by":"crossref","first-page":"1167","DOI":"10.1097\/CCM.0b013e31827c09f8","article-title":"Benchmarking the incidence and mortality of severe sepsis in the United States","volume":"41","author":"Gaieski","year":"2013","journal-title":"Crit. Care. Med."},{"issue":"10","key":"10.1016\/j.intimp.2023.110917_b0035","doi-asserted-by":"crossref","first-page":"2085","DOI":"10.1097\/CCM.0000000000001159","article-title":"Rehospitalizations Following Sepsis: Common and Costly","volume":"43","author":"Chang","year":"2015","journal-title":"Crit. Care. Med."},{"issue":"6","key":"10.1016\/j.intimp.2023.110917_b0040","doi-asserted-by":"crossref","first-page":"1491","DOI":"10.1097\/TA.0b013e318256e000","article-title":"Persistent inflammation and immunosuppression: a common syndrome and new horizon for surgical intensive care","volume":"72","author":"Gentile","year":"2012","journal-title":"J. Trauma Acute Care Surg."},{"issue":"5","key":"10.1016\/j.intimp.2023.110917_b0045","doi-asserted-by":"crossref","first-page":"1276","DOI":"10.1097\/CCM.0b013e3181d8cc1d","article-title":"Long-term mortality and quality of life in sepsis: a systematic review","volume":"38","author":"Winters","year":"2010","journal-title":"Crit. Care. Med."},{"issue":"8","key":"10.1016\/j.intimp.2023.110917_b0050","doi-asserted-by":"crossref","first-page":"5110","DOI":"10.4049\/jimmunol.174.8.5110","article-title":"Accelerated lymphocyte death in sepsis occurs by both the death receptor and mitochondrial pathways","volume":"174","author":"Hotchkiss","year":"2005","journal-title":"J. Immunol."},{"issue":"11","key":"10.1016\/j.intimp.2023.110917_b0055","doi-asserted-by":"crossref","first-page":"2413","DOI":"10.3390\/ijms18112413","article-title":"Targeting Immune Cell Checkpoints during Sepsis","volume":"18","author":"Patil","year":"2017","journal-title":"Int. J. Mol. Sci."},{"issue":"1","key":"10.1016\/j.intimp.2023.110917_b0060","doi-asserted-by":"crossref","first-page":"69","DOI":"10.1016\/j.ccc.2019.08.006","article-title":"Check Point Inhibitors and Their Role in Immunosuppression in Sepsis","volume":"36","author":"Wakeley","year":"2020","journal-title":"Crit. Care Clin."},{"issue":"2","key":"10.1016\/j.intimp.2023.110917_b0065","doi-asserted-by":"crossref","first-page":"R99","DOI":"10.1186\/cc10112","article-title":"Programmed death-1 levels correlate with increased mortality, nosocomial infection and immune dysfunctions in septic shock patients","volume":"15","author":"Guignant","year":"2011","journal-title":"Crit. Care"},{"key":"10.1016\/j.intimp.2023.110917_b0070","doi-asserted-by":"crossref","first-page":"157","DOI":"10.1146\/annurev-physiol-061121-040214","article-title":"Sepsis-Induced Immunosuppression","volume":"84","author":"Torres","year":"2022","journal-title":"Annu. Rev. Physiol."},{"issue":"9","key":"10.1016\/j.intimp.2023.110917_b0075","doi-asserted-by":"crossref","first-page":"2749","DOI":"10.1007\/s00436-020-06786-1","article-title":"Enhancing the antimalarial activity of artesunate","volume":"119","author":"Adebayo","year":"2020","journal-title":"Parasitol. Res."},{"issue":"18","key":"10.1016\/j.intimp.2023.110917_b0080","doi-asserted-by":"crossref","first-page":"4147","DOI":"10.1111\/bph.15158","article-title":"Artesunate interacts with the vitamin D receptor to reverse sepsis-induced immunosuppression in a mouse model via enhancing autophagy","volume":"177","author":"Shang","year":"2020","journal-title":"Br. J. Pharmacol."},{"key":"10.1016\/j.intimp.2023.110917_b0085","doi-asserted-by":"crossref","DOI":"10.1016\/j.intimp.2020.106863","article-title":"Artesunate reverses LPS tolerance by promoting ULK1-mediated autophagy through interference with the CaMKII-IP3R-CaMKK\u03b2 pathway","volume":"87","author":"Liu","year":"2020","journal-title":"Int. Immunopharmacol."},{"key":"10.1016\/j.intimp.2023.110917_b0090","article-title":"Design of Cecal Ligation and Puncture and Intranasal Infection Dual Model of Sepsis-Induced Immunosuppression","volume":"148","author":"Wang","year":"2019","journal-title":"J. Vis. Exp."},{"issue":"3","key":"10.1016\/j.intimp.2023.110917_b0095","doi-asserted-by":"crossref","first-page":"281","DOI":"10.1016\/0002-9343(93)90060-3","article-title":"Nosocomial pneumonia in ventilated patients: a cohort study evaluating attributable mortality and hospital stay","volume":"94","author":"Fagon","year":"1993","journal-title":"Am. J. Med."},{"issue":"3","key":"10.1016\/j.intimp.2023.110917_b0100","doi-asserted-by":"crossref","first-page":"786","DOI":"10.1378\/chest.108.3.786","article-title":"Bacteremic nosocomial pneumonia. A 7-year experience in one institution","volume":"108","author":"Taylor","year":"1995","journal-title":"Chest"},{"key":"10.1016\/j.intimp.2023.110917_b0105","doi-asserted-by":"crossref","first-page":"49","DOI":"10.1016\/j.intimp.2016.11.011","article-title":"Systematic investigation on the turning point of over-inflammation to immunosuppression in CLP mice model and their characteristics","volume":"42","author":"Deng","year":"2017","journal-title":"Int. Immunopharmacol."},{"issue":"11","key":"10.1016\/j.intimp.2023.110917_b0110","doi-asserted-by":"crossref","first-page":"6952","DOI":"10.4049\/jimmunol.166.11.6952","article-title":"Sepsis-induced apoptosis causes progressive profound depletion of B and CD4+ T lymphocytes in humans","volume":"166","author":"Hotchkiss","year":"2001","journal-title":"J. Immunol."},{"issue":"9","key":"10.1016\/j.intimp.2023.110917_b0115","doi-asserted-by":"crossref","DOI":"10.1038\/emm.2017.146","article-title":"Impaired polyfunctionality of CD8(+) T cells in severe sepsis patients with human cytomegalovirus reactivation","volume":"49","author":"Choi","year":"2017","journal-title":"Exp. Mol. Med."},{"issue":"7","key":"10.1016\/j.intimp.2023.110917_b0120","doi-asserted-by":"crossref","first-page":"1230","DOI":"10.1097\/00003246-199907000-00002","article-title":"Apoptotic cell death in patients with sepsis, shock, and multiple organ dysfunction","volume":"27","author":"Hotchkiss","year":"1999","journal-title":"Crit. Care. Med."},{"issue":"3","key":"10.1016\/j.intimp.2023.110917_b0125","doi-asserted-by":"crossref","first-page":"1401","DOI":"10.4049\/jimmunol.0902307","article-title":"IL-15 prevents apoptosis, reverses innate and adaptive immune dysfunction, and improves survival in sepsis","volume":"184","author":"Inoue","year":"2010","journal-title":"J. Immunol."},{"issue":"6","key":"10.1016\/j.intimp.2023.110917_b0130","doi-asserted-by":"crossref","first-page":"R220","DOI":"10.1186\/cc9354","article-title":"PD-L1 blockade improves survival in experimental sepsis by inhibiting lymphocyte apoptosis and reversing monocyte dysfunction","volume":"14","author":"Zhang","year":"2010","journal-title":"Crit. Care"},{"key":"10.1016\/j.intimp.2023.110917_b0135","doi-asserted-by":"crossref","DOI":"10.1016\/j.biopha.2019.108609","article-title":"Tanshinone IIA attenuates sepsis-induced immunosuppression and improves survival rate in a mice peritonitis model","volume":"112","author":"Gao","year":"2019","journal-title":"Biomed. Pharmacother."},{"issue":"Suppl 1","key":"10.1016\/j.intimp.2023.110917_b0140","doi-asserted-by":"crossref","first-page":"20","DOI":"10.1186\/s40635-020-00309-z","article-title":"Role of the adaptive immune response in sepsis","volume":"8","author":"Brady","year":"2020","journal-title":"Intensive Care Med. Exp."},{"issue":"3","key":"10.1016\/j.intimp.2023.110917_b0145","doi-asserted-by":"crossref","first-page":"202","DOI":"10.1046\/j.1469-0691.2003.00518.x","article-title":"Lymphocyte subset numbers depend on the bacterial origin of sepsis","volume":"9","author":"Holub","year":"2003","journal-title":"Clin. Microbiol. Infect."},{"issue":"5","key":"10.1016\/j.intimp.2023.110917_b0150","doi-asserted-by":"crossref","DOI":"10.1172\/jci.insight.98960","article-title":"Interleukin-7 restores lymphocytes in septic shock: the IRIS-7 randomized clinical trial","volume":"3","author":"Francois","year":"2018","journal-title":"JCI insight"},{"issue":"1","key":"10.1016\/j.intimp.2023.110917_b0155","doi-asserted-by":"crossref","first-page":"116","DOI":"10.4049\/jimmunol.1402473","article-title":"Polymicrobial Sepsis Increases Susceptibility to Chronic Viral Infection and Exacerbates CD8+ T Cell Exhaustion","volume":"195","author":"Condotta","year":"2015","journal-title":"J. Immunol."},{"issue":"6","key":"10.1016\/j.intimp.2023.110917_b0160","doi-asserted-by":"crossref","first-page":"1961","DOI":"10.4049\/jimmunol.1700375","article-title":"Cutting Edge: 2B4-Mediated Coinhibition of CD4(+) T Cells Underlies Mortality in Experimental Sepsis","volume":"199","author":"Chen","year":"2017","journal-title":"J. Immunol."},{"issue":"2","key":"10.1016\/j.intimp.2023.110917_b0165","doi-asserted-by":"crossref","first-page":"121","DOI":"10.1038\/nrneph.2017.165","article-title":"Advances in the understanding and treatment of sepsis-induced immunosuppression","volume":"14","author":"Venet","year":"2018","journal-title":"Nat. Rev. Nephrol."},{"issue":"1","key":"10.1016\/j.intimp.2023.110917_b0170","doi-asserted-by":"crossref","first-page":"124","DOI":"10.1186\/s13054-016-1301-x","article-title":"Monocyte programmed death ligand-1 expression after 3\u20134 days of sepsis is associated with risk stratification and mortality in septic patients: a prospective cohort study","volume":"20","author":"Shao","year":"2016","journal-title":"Crit. Care"},{"issue":"1","key":"10.1016\/j.intimp.2023.110917_b0175","doi-asserted-by":"crossref","first-page":"40","DOI":"10.1097\/SHK.0000000000000688","article-title":"Flt3 Ligand Treatment Attenuates T Cell Dysfunction and Improves Survival in a Murine Model of Burn Wound Sepsis","volume":"47","author":"Patil","year":"2017","journal-title":"Shock"},{"issue":"2","key":"10.1016\/j.intimp.2023.110917_b0180","doi-asserted-by":"crossref","first-page":"233","DOI":"10.1189\/jlb.0110037","article-title":"Delayed administration of anti-PD-1 antibody reverses immune dysfunction and improves survival during sepsis","volume":"88","author":"Brahmamdam","year":"2010","journal-title":"J. Leukoc. Biol."},{"issue":"6","key":"10.1016\/j.intimp.2023.110917_b0185","doi-asserted-by":"crossref","first-page":"496","DOI":"10.1038\/82741","article-title":"Caspase inhibitors improve survival in sepsis: a critical role of the lymphocyte","volume":"1","author":"Hotchkiss","year":"2000","journal-title":"Nat. Immunol."},{"issue":"1","key":"10.1016\/j.intimp.2023.110917_b0190","doi-asserted-by":"crossref","first-page":"R3","DOI":"10.1186\/cc13176","article-title":"Targeting the programmed cell death 1: programmed cell death ligand 1 pathway reverses T cell exhaustion in patients with sepsis","volume":"18","author":"Chang","year":"2014","journal-title":"Crit. Care"},{"issue":"7","key":"10.1016\/j.intimp.2023.110917_b0195","doi-asserted-by":"crossref","first-page":"670","DOI":"10.1038\/ni944","article-title":"BTLA is a lymphocyte inhibitory receptor with similarities to CTLA-4 and PD-1","volume":"4","author":"Watanabe","year":"2003","journal-title":"Nat. Immunol."},{"issue":"3","key":"10.1016\/j.intimp.2023.110917_b0200","doi-asserted-by":"crossref","first-page":"794","DOI":"10.1097\/01.CCM.0000256847.61085.A5","article-title":"Negative signaling contributes to T-cell anergy in trauma patients","volume":"35","author":"Bandyopadhyay","year":"2007","journal-title":"Crit. Care. Med."},{"issue":"1","key":"10.1016\/j.intimp.2023.110917_b0205","doi-asserted-by":"crossref","first-page":"38","DOI":"10.1097\/SHK.0b013e3182168cce","article-title":"Dose-dependent effect of anti-CTLA-4 on survival in sepsis","volume":"36","author":"Inoue","year":"2011","journal-title":"Shock"},{"issue":"22","key":"10.1016\/j.intimp.2023.110917_b0210","doi-asserted-by":"crossref","first-page":"3227","DOI":"10.1038\/sj.onc.1210414","article-title":"The ERK1\/2 mitogen-activated protein kinase pathway as a master regulator of the G1- to S-phase transition","volume":"26","author":"Meloche","year":"2007","journal-title":"Oncogene"},{"key":"10.1016\/j.intimp.2023.110917_b0215","article-title":"PD-1 Blockade Restores the Proliferation of Peripheral Blood Lymphocyte and Inhibits Lymphocyte Apoptosis in a BALB\/c Mouse Model of CP BVDV Acute Infection","volume":"12","author":"Liu","year":"2021","journal-title":"Front. Immunol."},{"issue":"4","key":"10.1016\/j.intimp.2023.110917_b0220","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pbio.3001199","article-title":"PD-L1 signaling on human memory CD4+ T cells induces a regulatory phenotype","volume":"19","author":"Fanelli","year":"2021","journal-title":"PLoS Biol."}],"container-title":["International Immunopharmacology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1567576923012420?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1567576923012420?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,27]],"date-time":"2025-10-27T17:59:20Z","timestamp":1761587960000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1567576923012420"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,11]]},"references-count":44,"alternative-id":["S1567576923012420"],"URL":"https:\/\/doi.org\/10.1016\/j.intimp.2023.110917","relation":{},"ISSN":["1567-5769"],"issn-type":[{"value":"1567-5769","type":"print"}],"subject":[],"published":{"date-parts":[[2023,11]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"The effect of artesunate to reverse CLP-induced sepsis immunosuppression mice with secondary infection is tightly related to reducing the apoptosis of T cells via decreasing the inhibiting receptors and activating MAPK\/ERK pathway","name":"articletitle","label":"Article Title"},{"value":"International Immunopharmacology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.intimp.2023.110917","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2023 Elsevier B.V. All rights reserved.","name":"copyright","label":"Copyright"}],"article-number":"110917"}}